Introduction

Abdominal lymph node biopsy is a procedure performed by interventional radiologists to obtain tissue samples from enlarged or suspicious lymph nodes within the abdominal cavity. Using real-time imaging guidance, the radiologist can precisely target these nodes through a small skin puncture, eliminating the need for open surgical excision. This approach has become the standard of care in most institutions worldwide, offering patients a safe, accurate and minimally invasive pathway to diagnosis. The ability to obtain high-quality tissue samples with minimal patient discomfort and a low complication rate makes this one of the most valuable procedures in modern interventional radiology practice.

What is a Lymph Node and Why to Biopsy It?

Lymph nodes are small, bean-shaped glandular structures distributed throughout the body as part of the lymphatic system. They serve as filtering stations for lymphatic fluid and play a central role in immune surveillance. In the abdomen, lymph nodes are clustered along major vascular structures including the aorta, inferior vena cava, celiac axis, superior mesenteric artery and iliac vessels, as well as in the retroperitoneum, mesentery and peripancreatic regions. When abdominal lymph nodes become enlarged or develop suspicious characteristics on cross-sectional imaging, tissue sampling is required to establish a definitive diagnosis. The causes of abdominal lymphadenopathy are broad and include lymphoma, metastatic malignancy, tuberculosis, sarcoidosis, reactive inflammatory conditions and fungal infections. A biopsy provides tissue that can be analyzed by pathologists to identify the exact nature of the disease and guide treatment decisions.

Indications for the Procedure

This procedure is indicated whenever abdominal lymphadenopathy requires histological characterization. The most common clinical scenarios include newly detected lymphadenopathy in a patient with suspected lymphoma, workup of metastatic disease from a known or unknown primary tumor, unexplained constitutional symptoms such as fever, night sweats and weight loss in association with enlarged nodes, evaluation of infectious or granulomatous conditions and assessment of disease recurrence or treatment response in patients already undergoing oncological management. In each of these situations, obtaining an accurate tissue diagnosis is essential before initiating therapy.

Pre-Procedure Preparation

Careful preparation is key to a safe and successful biopsy. The interventional radiologist begins by reviewing all available imaging including recent CT, MRI or PET-CT scans to identify the target lymph node, assess its size and location and plan the optimal needle access route. Pre-procedure blood tests including a full blood count and coagulation studies are obtained to evaluate bleeding risk. Any anticoagulant or antiplatelet medications are reviewed and may be temporarily withheld in consultation with the referring physician. The patient is asked to fast for a few hours before the procedure. A detailed discussion with the patient covers the purpose of the biopsy, the technique involved, the expected benefits and the potential risks. Written informed consent is obtained prior to proceeding.

How the Procedure is Performed

The patient is positioned on the procedure table in the supine or lateral decubitus position, depending on the location of the target lymph node. The skin over the planned puncture site is thoroughly cleaned with antiseptic solution and sterile drapes are applied. Local anesthetic is injected into the skin and deeper soft tissues along the intended needle path to ensure patient comfort throughout the procedure.

Using real-time imaging, the radiologist identifies the target node on the monitor and carefully maps a safe trajectory that avoids adjacent blood vessels, bowel loops, the ureter and other vital structures. A small skin nick is made with a scalpel to facilitate needle entry. A coaxial technique is most commonly employed, in which an outer guide needle is first advanced to the surface of the lymph node. Through this guide needle, a spring-loaded core biopsy needle is then inserted and fired rapidly to obtain a cylindrical tissue core from within the node. This rapid automated action minimizes patient movement and ensures a clean, well-preserved tissue sample.

Multiple passes are typically performed — usually between two and four — to collect sufficient tissue for the full range of laboratory studies. The cores are carefully placed into appropriate fixative solutions or transport media, depending on the tests requested. These may include routine histology with hematoxylin and eosin staining, immunohistochemistry to characterize cell surface markers, flow cytometry for lymphoma subtyping, cytogenetic analysis and molecular or next-generation sequencing studies for targeted therapy planning. After all samples are collected, the needle is removed and firm pressure is applied to the puncture site to achieve hemostasis.

Post-Procedure Monitoring and Recovery

Following the biopsy, the patient is transferred to a recovery area where vital signs and the puncture site are monitored for one to two hours. The vast majority of patients experience no significant complications during this period and are discharged home the same day. Patients are advised to rest for the remainder of the day, avoid strenuous physical activity for twenty-four hours, keep the puncture site clean and dry and report any worsening pain, swelling, fever or bleeding to their clinical team. Results from the pathology laboratory are typically available within two to five working days, depending on the complexity of the tests requested.

Risks and Complications

Abdominal lymph node biopsy is a safe procedure with a very low overall complication rate when performed by an experienced interventional radiologist with appropriate imaging guidance. Minor complications include transient pain or discomfort at the puncture site and small hematoma formation, both of which resolve without intervention. Serious complications are uncommon and may include significant hemorrhage requiring treatment, infection, pneumothorax if the biopsy approach is close to the diaphragm or inadvertent injury to an adjacent structure such as the bowel or ureter. Meticulous pre-procedure planning, precise real-time guidance and the use of fine-gauge needles keep these risks to a minimum.

Diagnostic Accuracy and Clinical Value

The diagnostic accuracy of image-guided core needle biopsy for abdominal lymph nodes is well established, with reported success rates of 85 to 95 percent across published literature. Importantly, core biopsy provides not just a diagnosis but also sufficient tissue architecture for advanced ancillary testing. This is particularly significant in lymphoma, where accurate subtype classification — such as diffuse large B-cell lymphoma, follicular lymphoma or Hodgkin lymphoma — directly determines the chemotherapy regimen. Similarly, in metastatic disease, molecular profiling of biopsy tissue increasingly guides the selection of targeted therapies and immunotherapy agents.

Conclusion

Abdominal lymph node biopsy performed under image guidance is one of the cornerstones of modern interventional radiology. It delivers a definitive tissue diagnosis through a safe, well-tolerated and minimally invasive technique that has replaced the need for surgical excision in most clinical scenarios. For patients facing a new diagnosis of lymphoma, metastatic cancer or other forms of abdominal lymphadenopathy, this procedure represents the fastest and safest route to an accurate diagnosis — and ultimately, to the right treatment.